Rural Communities Opioid Response Program – Psychostimulant Support

Funding Agency:
Health Resources and Services Administration

The Rural Communities Opioid Response Program (RCORP) is a multi-year initiative by the Health Resources and Services Administration (HRSA) aimed at reducing the morbidity and mortality of substance use disorder (SUD), including opioid use disorder (OUD), in high risk rural communities. This notice announces the opportunity to apply for funding under RCORP-Psychostimulant Support (RCORP-PS). RCORP-PS will advance RCORP’s overall goal by strengthening and expanding prevention, treatment, and recovery services for rural individuals who misuse psychostimulants to enhance their ability to access treatment and move towards recovery.

Over the course of a three-year period of performance, RCORP-PS award recipients will implement a set of core psychostimulant use disorder prevention, treatment, and recovery activities, as outlined in Section IV.2. For the purposes of this funding opportunity, psychostimulants include methamphetamine and other illegal drugs, such as cocaine and ecstasy, as well as prescription stimulants for conditions such as attention deficit hyperactivity disorder (ADHD) or depression.1 Applicants should detail in the "Project Abstract" and “Needs Assessment” sections of the Project Narrative which psychostimulants they propose to target with the funding.

Given the complex and multifaceted nature of psychostimulant use disorders, as well as the need to secure community buy-in, HRSA requires that applicants be part of broad, multi-sectoral consortia consisting of four or more separately-owned (i.e., different Employment Identification Numbers (EINs)) entities, including the applicant organization.2 A majority, or at least 50 percent, of separately owned consortium members must be physically located in HRSA-designated rural areas, as defined by the Rural Health Grants Eligibility Analyzer.

The target population for this award are 1) individuals who are at risk for, have been diagnosed with, and/or are in treatment and/or recovery for psychostimulant use disorders; 2) their families and/or caregivers; and 3) other community members who reside in HRSA-designated rural areas.

In general, multiple applications associated with the same DUNS number or Unique Entity Identifier (UEI), and/or EIN are not allowable. However, HRSA recognizes a growing trend towards greater consolidation within the rural health care industry and the possibility that multiple organizations with the same EIN and/or DUNS number or UEI could be located in different rural service areas that have a need for SUD/OUD services. Therefore, at HRSA’s discretion, separate applications associated with a single DUNS number and/or EIN may be considered eligible for this funding opportunity. See more information in Attachment 8.


  • Duke Internal: Interested applicants from within Duke should contact as early as possible.
  • Application Due Date: April 12, 2021

Agency Website

Eligibility Requirements

Eligible applicants include all domestic public or private, non-profit or for-profit entities, including faith-based and community-based organizations, and federallyrecognized tribes and tribal organizations. In addition to the 50 U.S. states, only organizations in the District of Columbia, Guam, the Commonwealth of Puerto Rico, the Northern Mariana Islands, American Samoa, the U.S. Virgin Islands, the Federated State of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau may apply. If you are located outside the 50 states, you must still meet the eligibility requirements.



Amount Description

HRSA estimates approximately $7,500,000 to be available to fund up to 15 recipients. The actual amount available will not be determined until enactment of the final FY 2021 federal appropriation. You may apply for a ceiling amount of up to $500,000 total cost (includes both direct and indirect, facilities and administrative costs) for the three-year period of performance. The period of performance is September 1, 2021 through August 31, 2024 (3 years).

Funding Type





Community Outreach and Engagement
Medical - Clinical Science
Medical - Translational
Social Sciences

External Deadline

April 12, 2021